Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems
- PMID: 36847211
- DOI: 10.1002/anie.202218000
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems
Abstract
The discovery of the medicinal properties of gold complexes has fuelled the design and synthesis of new anticancer metallodrugs, which have received special attention due to their unique modes of action. Current research in the development of gold compounds with therapeutic properties is predominantly focused on the molecular design of drug leads with superior pharmacological activities, e.g., by introducing targeting features. Moreover, intensive research aims at improving the physicochemical properties of gold compounds, such as chemical stability and solubility in the physiological environment. In this regard, the encapsulation of gold compounds in nanocarriers or their chemical grafting onto targeted delivery vectors could lead to new nanomedicines that eventually reach clinical applications. Herein, we provide an overview of the state-of-the-art progress of gold anticancer compounds, andmore importantly we thoroughly revise the development of nanoparticle-based delivery systems for gold chemotherapeutics.
Keywords: Anticancer; Gold Compounds; Nano-Formulation; Nanomedicine; Nanoparticles.
© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Similar articles
-
Controlled-release systems for metal-based nanomedicine: encapsulated/self-assembled nanoparticles of anticancer gold(III)/platinum(II) complexes and antimicrobial silver nanoparticles.Adv Mater. 2014 Aug 20;26(31):5550-7. doi: 10.1002/adma.201305617. Epub 2014 Mar 24. Adv Mater. 2014. PMID: 24664412 Review.
-
Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.Curr Med Chem. 2018 Feb 12;25(4):437-461. doi: 10.2174/0929867324666170529125229. Curr Med Chem. 2018. PMID: 28554319 Review.
-
Medicinal Chemistry of Gold Anticancer Metallodrugs.Met Ions Life Sci. 2018 Feb 5;18:/books/9783110470734/9783110470734-007/9783110470734-013.xml. doi: 10.1515/9783110470734-013. Met Ions Life Sci. 2018. PMID: 29394026 Review.
-
Nanocarriers for anticancer drugs--new trends in nanomedicine.Curr Drug Metab. 2013 Jun;14(5):547-64. doi: 10.2174/1389200211314050005. Curr Drug Metab. 2013. PMID: 23687925 Review.
-
[Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].Yakugaku Zasshi. 2021;141(3):323-326. doi: 10.1248/yakushi.20-00179-3. Yakugaku Zasshi. 2021. PMID: 33642498 Review. Japanese.
Cited by
-
In-vitro antiproliferative evaluation of newly synthesized titanium(IV) metallacyclic complexes on HeLa and MCF7 cell lines.Sci Rep. 2025 Aug 8;15(1):29066. doi: 10.1038/s41598-025-13995-0. Sci Rep. 2025. PMID: 40781461 Free PMC article.
-
Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers.RSC Med Chem. 2023 Nov 21;15(1):139-150. doi: 10.1039/d3md00334e. eCollection 2024 Jan 25. RSC Med Chem. 2023. PMID: 38283233 Free PMC article.
-
Solubilization techniques used for poorly water-soluble drugs.Acta Pharm Sin B. 2024 Nov;14(11):4683-4716. doi: 10.1016/j.apsb.2024.08.027. Epub 2024 Sep 2. Acta Pharm Sin B. 2024. PMID: 39664427 Free PMC article. Review.
-
Stoichiometry effect on the structure, coordination and anticancer activity of gold(I/III) bisphosphine complexes.Dalton Trans. 2025 Jan 28;54(5):2018-2026. doi: 10.1039/d4dt01663g. Dalton Trans. 2025. PMID: 39688257 Free PMC article.
-
Gold(i) and gold(iii) complexes of triazolyl-functionalised NHCs.RSC Adv. 2025 May 30;15(23):18123-18141. doi: 10.1039/d5ra02655e. eCollection 2025 May 29. RSC Adv. 2025. PMID: 40453112 Free PMC article.
References
-
- H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA Cancer J. Clin. 2021, 71, 209-249.
-
- S. Reardon, Science 2011, 333, 558-559.
-
- S. Pilleron, D. Sarfati, M. Janssen-Heijnen, J. Vignat, J. Ferlay, F. Bray, I. Soerjomataram, Int. J. Cancer 2019, 144, 49-58.
-
- World Health Organization, WHO, WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All., World Health Organization, Geneva, 2020.
-
- B. Rosenberg, Interdiscip. Sci. Rev. 1978, 3, 134-147.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical